Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-18-024270

Chief Medical Officer sold 1,760 shares at $18.58 ($32,699)

  • Chief Medical Officer acquired 1,760 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

FINCK BARBARA K · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-09-10 Exercise or conversion : show line 1 in the form +1,760 $1.42 $2,499 38,803 D
2018-09-10 Sale : show line 2 in the form −1,760 $18.58 $32,699 37,043 D
Open-market sales · 1,760 sh · avg $18.58 · $32,699

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-09-10 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −1,760 82,941 D
Loading xslF345X03/doc4.xml…